Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
ORENCIA Trockensub 250 mg mit Spritze Durchstf
Drug
Orencia, Pulver zur Herstellung eines Infusionslösungskonzentrats
Rheumatoide Arthritis, Polyartikuläre juvenile idiopathische Arthritis
07.15.0. – immunosuppressants
HAM – Human medicine
PULPI – powder for concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
8/3/2007
12/31/9999
Dosage strength
Orencia 250 mg, Pulver zur Herstellung eines Infusionslösungkonzentrats
Rheumatoide Arthritis, Polyartikuläre juvenile idiopathische Arthritis
01
Z – approved
Package
7680577690014
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component Freeze-dried preparation
250 mg abataceptum
maltosum monohydricum
natrii dihydrogenophosphas monohydricus
natrii chloridum
8.613 mg natrium
natrii dihydrogenophosphas monohydricus
natrii chloridum
8.613 mg natrium
Spezialitätenliste***
SL
-
-
390.60
None
Yes
10%
No
Authorisation holder
7601001010703
Bristol-Myers Squibb SA
Hinterbergstrasse 16
6312 Steinhausen (ZG)
Hinterbergstrasse 16
6312 Steinhausen (ZG)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.